Stanley D Glick, MD PhD

Scientific Advisor

Stan was a professor of pharmacology at Mount Sinai School of Medicine and chaired the pharmacology and neuroscience program at Albany Medical College. Dr. Glick’s major research interest focused on the neurobiology of drug addiction. His research was funded by the National Institute on Drug Abuse (NIDA) for forty years and he is a co-inventor of a novel group of agents (iboga alkaloid congeners) for treating drug addiction, including 18-methoxycoronaridine (18-MC). Dr. Glick has authored or co-authored over 450 experimental papers, reviews and abstracts, and has served on journal editorial boards and NIH advisory committees.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President and Board Director

Cynthia Hu, JD Portrait

Cynthia Hu, JD

Chief Legal Officer & Corporate Secretary

Daniel R Karlin, MD MA Portrait

Daniel R Karlin, MD MA

Chief Medical Officer

Dave Guebert Portrait

Dave Guebert

Chief Financial Officer

Robert Malenka, MD PhD Portrait

Robert Malenka, MD PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Member, Scientific Advisory Board Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Maria A Oquendo, MD PhD Portrait

Maria A Oquendo, MD PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Bryan L Roth, MD PhD Portrait

Bryan L Roth, MD PhD

Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Stanley D Glick, MD PhD Portrait

Stanley D Glick, MD PhD

Scientific Advisor

Matthew W Johnson, PhD Portrait

Matthew W Johnson, PhD

Clinical Advisor

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Matthias Liechti, MD PhD Portrait

Matthias Liechti, MD PhD

Scientific Collaborator & Advisor

Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Sarah Y Vinson, MD Portrait

Sarah Y Vinson, MD

Board Director, Member of Compensation, Nomination, and Governance Committees

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee

Stephen L Hurst, JD Portrait

Stephen L Hurst, JD

Co-Founder and Board Director

JR Rahn Portrait

JR Rahn

Co-Founder

Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder

Leonard Latchman Portrait

Leonard Latchman

Co-Founder